PD-1 blockade combined with COX inhibitor in patients with MSI-H/dMMR or high TMB, advanced or metastatic colorectal cancer (PCOX study)

Wu, ZH; Hu, HB; Zhang, JW; Cai, Y; Xie, XY; Ling, JY; Li, WW; Deng, YH

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):